Bala, Juanito E.
HRN: 20-71-39 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
10/17/2023
10/23/2023
IV
600mg
Q8
Non Healing Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes